Avalo Therapeutics (C6K0) Cash flow

0 Followers

Avalo Therapeutics Cash Flow

DE:C6K0's free cash flow for Q2 2026 was $-18.08M. For the 2026 fiscal year, DE:C6K0's free cash flow was decreased by $-2.40M and operating cash flow was $-18.08M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -51.46M	$ -49.06M	$ -30.68M	$ -26.75M	$ -70.89M
Investing Cash Flow	$ -81.72M	$ 356.00K	$ -133.00K	$ -95.00K	$ -113.00K
Financing Cash Flow	$ 14.59M	$ 175.85M	$ 25.04M	$ -14.70M	$ 106.76M
End Cash Position	$ 16.11M	$ 134.70M	$ 7.55M	$ 13.19M	$ 54.86M
Free Cash Flow	$ -51.46M	$ -49.06M	$ -30.84M	$ -26.85M	$ -71.00M

Currency in USD